tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

VOR Stock Latest News

Vor Bio announces new clinical data from VBP101 study
The FlyVor Bio announces new clinical data from VBP101 study
14d ago
VOR
Vor Biopharma Advances Innovative Blood Cancer Therapies
PremiumCompany Announcements
Vor Biopharma Advances Innovative Blood Cancer Therapies
14d ago
8K
VOR
Vor Bio announces new data, plans to approach FDA on trial design by year-end
PremiumThe Fly
Vor Bio announces new data, plans to approach FDA on trial design by year-end
14d ago
VOR
New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
PremiumPress Releases
New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
14d ago
VOR
Vor Bio to Participate in Upcoming Investor Conferences
PremiumPress Releases
Vor Bio to Participate in Upcoming Investor Conferences
23d ago
VOR
Vor Bio price target lowered to $3 from $10 at Barclays
PremiumThe FlyVor Bio price target lowered to $3 from $10 at Barclays
1M ago
VOR
Vor Bio reports Q2 EPS (41c) vs (45c) last year
Premium
The Fly
Vor Bio reports Q2 EPS (41c) vs (45c) last year
1M ago
VOR
Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update
Premium
Press Releases
Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update
1M ago
VOR
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2M ago
VOR
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2M ago
VOR
Voyager Therapeutics appoints Jorgensen as CFO
PremiumThe Fly
Voyager Therapeutics appoints Jorgensen as CFO
3M ago
VOR
VYGR
Vor Biopharma Announces Interim Financial Leadership Changes
PremiumCompany Announcements
Vor Biopharma Announces Interim Financial Leadership Changes
3M ago
8K
VOR
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesVor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
4M ago
VOR
Vor Bio price target lowered to $10 from $15 at Oppenheimer
Premium
The Fly
Vor Bio price target lowered to $10 from $15 at Oppenheimer
4M ago
VOR
Vor Bio reports Q1 EPS (45c), consensus (38c)
Premium
The Fly
Vor Bio reports Q1 EPS (45c), consensus (38c)
4M ago
VOR
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
5M ago
VOR
Vor Biopharma Welcomes Oncology Expert to Board of Directors
PremiumCompany Announcements
Vor Biopharma Welcomes Oncology Expert to Board of Directors
5M ago
8K
VOR
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
PremiumPress Releases
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
5M ago
VOR
Vor Bio to Participate in Upcoming Investor Conferences
PremiumPress Releases
Vor Bio to Participate in Upcoming Investor Conferences
6M ago
VOR
Vor Bio price target lowered to $12 from $15 at Stifel
PremiumThe FlyVor Bio price target lowered to $12 from $15 at Stifel
6M ago
VOR
Vor Bio price target lowered to $15 from $17 at Oppenheimer
Premium
The Fly
Vor Bio price target lowered to $15 from $17 at Oppenheimer
6M ago
VOR
Vor Bio reports Q4 EPS (39c), consensus (50c)
Premium
The Fly
Vor Bio reports Q4 EPS (39c), consensus (50c)
6M ago
VOR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >